Characterization of potential predictive biomarkers of response to nivolumab in CheckMate 141 in patients with squamous cell carcinoma of the head and neck (SCCHN).

被引：5

作者：

Concha-Benavente, Fernando

Gillison, Maura L.

Blumenschein, George R.

Harrington, Kevin

Fayette, Jerome

Colevas, A. Dimitrios

Licitra, Lisa

Kasper, Stefan

Even, Caroline

Worden, Francis P.

Saba, Nabil F.

Haddad, Robert I.

Tahara, Makoto

Hasegawa, Yasuhisa

Yen, Chia-Jui

Lynch, Mark John

Monga, Manish

Geese, William J.

Vokes, Everett E.

Ferris, Robert L.

机构：

[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[2] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA

[3] Ohio State Univ, Columbus, OH 43210 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, Houston, TX 77030 USA

[5] Royal Marsden Natl Inst Hlth Res Biomed Res Ctr, Inst Canc Res, London, England

[6] Ctr Leon Berard, Lyon, France

[7] Stanford Canc Inst, Stanford, CA USA

[8] Fdn Ist Ricovero Cura Carattere Sci, Ist Nazl Tumori, Milan, Italy

[9] Univ Hosp Essen, Essen, Germany

[10] Inst Gustave Roussy, Villejuif, France

[11] Univ Michigan, Ann Arbor, MI USA

[12] Winship Canc Inst, Atlanta, GA USA

[13] Dana Farber Canc Inst, Boston, MA 02115 USA

[14] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[15] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[16] Natl Cheng Kung Univ NCKU Hosp, Tainan, Taiwan

[17] Bristol Myers Squibb, Princeton, NJ USA

[18] Univ Chicago, Chicago, IL 60637 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.6050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6050

引用

页数：5